Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1990 Oct;9(10):3397-404.
doi: 10.1002/j.1460-2075.1990.tb07541.x.

Domains of U4 and U6 snRNAs required for snRNP assembly and splicing complementation in Xenopus oocytes

Affiliations

Domains of U4 and U6 snRNAs required for snRNP assembly and splicing complementation in Xenopus oocytes

P Vankan et al. EMBO J. 1990 Oct.

Abstract

Structure-function relationships in the vertebrate U4-U6 snRNP have been analysed by assaying the ability of mutant RNAs to form U4-U6 snRNPs and to function in splicing complementation in Xenopus oocytes. The mutants define three categories of domain within the RNAs. First, domains which are not essential for splicing. These include regions of U6 which have previously been implicated in the capping and transport to the nucleus of U6 RNA as well as, less surprisingly, regions of U4 and U6 which have been poorly conserved in evolution. Second, domains whose mutation reduces U4-U6 snRNP assembly or stability. This group includes mutations in both the proposed U4-U6 interaction domain, and also, in the case of U6, in a highly conserve sequence flanking stem I of the interaction domain. These mutants are all defective in splicing. Third, regions not required for U4-U6 assembly, but required for splicing complementation. This category defines domains which are likely to be required for specific contacts with other components of the splicing machinery. Combinations of mutants in the U4 and U6 interaction domain are used to show that there are not only requirements for base complementarity but also for specific sequences in these regions.

PubMed Disclaimer

References

    1. Proc Natl Acad Sci U S A. 1981 May;78(5):2737-41 - PubMed
    1. EMBO J. 1984 Jun;3(6):1357-63 - PubMed
    1. Cell. 1985 Oct;42(3):737-50 - PubMed
    1. Science. 1985 Dec 20;230(4732):1344-9 - PubMed
    1. Cell. 1986 Aug 29;46(5):691-6 - PubMed

Substances